Filter
2943
Filtered Results: 2943
Text search:
cohort
Featured
Recommendations
276
New Publications
598
Language
Document type
No document type
1559
Studies & Reports
541
Guidelines
516
Manuals
103
Strategic & Response Plan
81
Fact sheets
68
Situation Updates
28
Training Material
25
Infographics
9
Resource Platforms
5
Online Courses
5
Brochures
3
Countries / Regions
Global
98
India
92
Western and Central Europe
85
Kenya
81
South Africa
80
Latin America and the Carribbean
70
Brazil
52
Russia
51
Africa
47
Ethiopia
47
Eastern Europe
46
Rwanda
45
Malawi
43
Uganda
37
Ukraine
36
Nepal
33
Nigeria
33
Myanmar / Burma
32
Bangladesh
30
Liberia
29
Sierra Leone
28
Senegal
26
Colombia
25
Ghana
25
Germany
25
Zambia
25
Congo, Democratic Republic of
23
Mozambique
22
Asia
22
Argentina
21
Philippines
20
Tanzania
20
Middle East and North Africa
19
Paraguay
19
Lesotho
18
Zimbabwe
17
Syria
16
West and Central Africa
16
Eastern Europe and Central Asia
16
Indonesia
16
Chile
15
South–East Asia Region
15
East and Southern Africa
15
Ecuador
15
Namibia
14
Benin
13
Cameroon
13
Burkina Faso
13
Peru
13
Venezuela
12
Pakistan
12
Haiti
10
Cambodia
10
Tajikistan
9
Angola
9
Botswana
9
Guinea
8
Western Pacific Region
7
Bolivia
7
Central African Republic
7
El Salvador
6
Guinea-Bissau
6
North America
6
Spain
6
Yemen
6
Georgia
6
Eswatini/ Swaziland
6
China
5
USA
5
Jordan
5
France
5
Mali
5
Thailand
4
Turkey
4
Southern Africa
4
Côte d’Ivoire / Ivory Coast
4
Madagascar
4
North Macedonia
3
Mexico
3
Kazakhstan
3
Albania
3
Niger
3
Afghanistan
3
Armenia
3
Dominican Republic
3
Portugal
3
Vietnam
3
Moldova
3
Sri Lanka
3
Egypt
3
Sudan
3
Guatemala
3
Timor Leste/ East Timor
2
Estonia
2
Kyrgyzstan
2
Congo-Brazzaville
2
Burundi
2
Italy
2
United Kingdom
2
Belarus
2
Lebanon
2
Honduras
2
Bhutan
2
Iraq
2
Serbia
1
Gambia
1
Togo
1
Canada
1
Singapore
1
Uzbekistan
1
Ireland
1
Uruguay
1
Belgium
1
Mauritius
1
Azerbaijan
1
Latvia
1
Nicaragua
1
Romania
1
Palestine
1
Chad
1
South Sudan
1
Cuba
1
Authors & Publishers
Publication Years
Category
Countries
1049
Clinical Guidelines
307
Public Health
156
Women & Child Health
131
Key Resources
51
Capacity Building
24
Pharmacy & Technologies
12
Toolboxes
COVID-19
450
TB
400
HIV
363
Mental Health
258
NCDs
99
Rapid Response
72
Caregiver
66
NTDs
63
Disability
57
Planetary Health
53
Ebola
49
AMR
47
Global Health Education
33
Refugee
28
Pharmacy
28
Polio
25
Zika
22
Conflict
18
Cholera
13
Health Financing Toolbox
12
Natural Hazards
7
Specific Hazards
5
Uso de doxiciclina para prevenção e tratamento de pacientes com Covid-19
24 Nov. 2021; This guidance provides considerations and a series of options that can be used to inform country strategies to minimise risk associated with shortages of personal protective equipment (PPE).
Re-use and reprocessing of single use PPE must be a last-resort temporary measure that is impl...
21 January 2022
The overall threat posed by Omicron largely depends on four key questions: (i) how transmissible the variant is; (ii) how well vaccines and prior infection protect against infection, transmission, clinical disease and death; (iii) how virulent the variant is compared to other varian...
Why bold action against inequalities is needed to en AIDS, stop COVID-19 and prepare for future pandemics
This publication provides managers with guidance on how to create basic HIV prevention cascades as a starting point to enhance their ability to monitor and improve their programming and to facilitate comparisons of programme effectiveness across sites.
Using Epidemiology to Support Primary Health Care. Updated version of the WHO handbook published in the early 1990's entitled: Manual of Epidemiology for District Health Management or those with an interest in applied epidemiology in primary health care and district health systems
11 august 2022, updated version
This guideline covers identifying, assessing and managing the long-term effects of COVID-19, often described as ‘long COVID’. It makes recommendations about care in all healthcare settings for adults, children and young people who have new or ongoing symptoms 4 weeks or more after the start of a...
Klinische Falldefinition einer Post-COVID-19-Erkrankung gemäß Delphi-Konsens, 6.Oktober 2021
recommended
Die WHO hat mit Hilfe der Delphi-Methode eine klinische Falldefinition für das Post-COVID-19-Syndrom entwickelt, die 12 Domänen umfasst und in allen Bereichen verwendet werden kann. Diese erste Version wurde von Patienten, Forschern und anderen Personen aus allen WHO-Regionen entwickelt, wobei dav...
L'OMS a développé une définition de cas clinique de l'état post COVID-19 par la méthodologie Delphi qui comprend 12 domaines, disponible pour une utilisation dans tous les contextes. Cette première version a été élaborée par des patients, des chercheurs et d'autres personnes, représentant...
The world is facing an unprecedented range of emergencies. In reaction to these complex adversities, many people experience considerable distress and impairment, and a minority may even go on to develop mental health conditions. Meanwhile, those with pre-existing mental health conditions may experie...
Adolescent girls and young women (AGYW) remain disproportionately affected by HIV in Eastern and Southern Africa (ESA), with 26 per cent of new infections attributed to this population. AGYW face many personal, social and structural barriers to access, uptake and use of traditional HIV prevention me...
Development of one or more vaccines for Neisseria gonorrhoeae is an important objective for sexual and reproductive health worldwide, and for the fight against antimicrobial resistance.
WHO preferred product characteristics (PPCs) provide strategic guidance as to WHO’s preferences for new vacci...
Interim guidance, 26 October 2021
This interim guidance has been developed on the basis of the advice issued by the Strategic Advisory Group of Experts (SAGE) on Immunization at its meeting on 5 October 2021.
SAGE said moderately and severely immunocompromised persons should be offered an addition...
Overview
16 Dec 2021. This interim guidance pertains to heterologous primary and heterologous boosting schedules of Covid-19 vaccines. It focuses on heterologous schedules combining multiple vaccine platforms (e.g. a vectored vaccine followed by an mRNA vaccine).
The report offers a snapshot of the drivers behind the persistent exclusion of persons with disabilities and proposes a framework to build an actionable agenda building on promising practices available in the region. The COVID-19 pandemic has laid bare the urgent need to build more inclusive and res...
Consensual Recommendation for treatment of COVID-19 in older adults
